Position history for FMR LLC's holdings in CYTOMX THERAPEUTICS INC.
FMR LLC holds 32M shares of CTMX (CYTOMX THERAPEUTICS INC.), worth $150.2M as of 2026-Q1. The position was increased (+29.4% shares). CTMX represents 0.0% of FMR LLC's portfolio.
Current Value
$150.2M
Current Shares
32M
Total Value Change
+$149.9M
Total Shares Change
+31.6M
Other major holders of CTMX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 32M |
+29.4% |
| $150.2M |
| 0.0% |
| $4.81 |
38 |
| 2025-Q4 | Increased | 24.7M | +60.4% | $105.2M | 0.0% | $4.16 | 43 |
| 2025-Q3 | Increased | 15.4M | +66.7% | $49.1M | 0.0% | $3.23 | 43 |
| 2025-Q2 | Increased | 9.2M | +8429.9% | $21M | 0.0% | $2.25 | 46 |
| 2025-Q1 | Decreased | 108,311 | -64.7% | $68,864 | 0.0% | $0.63 | 0 |
| 2024-Q4 | New | 306,783 | - | $315,986 | 0.0% | $1.02 | 36 |